Dose-response associations between accelerometry measured physical activity and sedentary time with all-cause mortality: a systematic review and harmonised meta-analysis
posted on 2019-07-18, 11:53authored byUlf Ekelund, Jakob Tarp, Jostein Steene-Johannessen, Bjørge H. Hansen, Barbara Jefferis, Morten W. Fagerland, Peter Whincup, Keith M. Diaz, Steven P. Hooker, Ariel Chernofsky, Martin G. Larson, Nicole Spartano, Ramachandran S. Vasan, Ing-Mari Dohrn, Maria Hagströmer, Charlotte Edwardson, Thomas Yates, Eric Shiroma, Sigmund A. Anderssen, I-Min Lee
Objective: To examine the dose-response associations between accelerometer assessed total
physical activity, different intensities of activity, and sedentary time with all-cause mortality.
Design: Systematic review and harmonised meta-analysis.
Data Sources: Five databases (PubMed, PsycINFO, Embase, Web of Science, Sport Discus) from
database inception until July 31st 2018.
Eligibility Criteria: Prospective cohort studies assessing physical activity and sedentary time by
accelerometry; had data on individual level exposure and outcome (all-cause mortality); and
reported effect estimates as hazard ratios (HR), odds ratios (OR) or relative risk (RR) with 95%
confidence intervals (95% CI) for all-cause mortality.
Data Extraction and Analysis: Guidelines for meta-analyses and systematic reviews for observational
studies and PRISMA guidelines were followed. Two authors independently screened all titles and
abstracts. One author performed a full-text review and one author extracted the data. Two authors
independently assessed the risk of bias. Individual level participant data were harmonised and
analysed at study level. Exposure data were categorised by quartiles at study level and study specific
associations with all-cause mortality were analysed using Cox proportional hazards regression
analyses. Study specific results were thereafter summarised using random-effects meta-analysis.
Main Outcome: All-cause mortality
Results: Thirty-nine studies were retrieved for full text review; 10 were eligible for inclusion, 3 of
these studies were excluded due to harmonisation challenges and 1 study did not participate. Two
additional pertinent studies with unpublished mortality data were also included. Thus, individual
level data from eight studies (n=36,383; mean age 62.6 years; 72.8% women), with median follow-up
time of 5.8 years (range 3.0 to 14.5 years) during which 2,149 (5.9%) died, were analysed. Any
physical activity, regardless of intensity, was associated with lower risk of mortality with a non-linear,
dose-response. Hazards ratios for mortality were 1.00 (referent), 0.48 (95% confidence interval: 0.43
to 0.54), 0.34 (0.26 to 0.45) and 0.27 (0.23 to 0.32) for increasing quartiles for total physical activity.
Corresponding hazards ratios for light-intensity activity were 1.00, 0.60 (0.54 to 0.68), 0.44 (0.38 to
0.51), and 0.38 (0.28 to 0.51); and 1.00, 0.64 (0.55 to 0.74), 0.55 (0.40 to 0.74), and 0.52 (0.43 to
0.61) for moderate-to-vigorous intensity activity. For sedentary time, hazards ratios were 1.00
(referent), 1.28 (1.09 to 1.51), 1.71 (1.36 to 2.15) and 2.63 (1.94 to 3.56).
Conclusion: Higher levels of total physical activity, at any intensity, and less sedentary time, are
associated with substantially reduced risk for premature mortality with evidence of a non-linear
dose-response pattern in middle-aged and older individuals.
Systematic Review Registration: PROSPERO 2018 CRD42018091808
Funding
The individual studies contributing to this harmonised meta-analysis were funded from the
following sources: The ABC-study was funded by Stockholm County Council, the Swedish National
Centre for Research in Sports and the project ALPHA, which received funding from the European
Union in the framework of the Public Health Programme and Folksam Research Foundation, Sweden;
The British Regional Heart Study was funded by project and programme grants from the British Heart
Foundation [PG/13/86/30546 and RG/13/16/30528]; The Framingham Heart Study’s data collection
and analysis was funded by the National Institutes of Health, National Heart, Lung, and Blood
Institute (NHLBI)-N01-HC25195; Health and Human Services (HHS) N268201500001I; R01-AG047645;
R01-HL131029; and the American Heart Association (15GPSGC24800006); The Norwegian National
Physical Activity Surveillance Study was supported by the Norwegian Directorate for Public Health
and the Norwegian School of Sport Sciences. JT is funded by the Research Council of Norway
(249932/F20); The REGARDS study was supported by a cooperative agreement U01-NS041588 and
investigator initiated grant R01-NS061846 from the National Institute of Neurological Disorders and
Stroke of the National Institutes of Health. Additional funding was provided by an unrestricted
research grant from The Coca-Cola Company; The Walking Away from type 2 Diabetes study was
supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in
Applied Health Research and Care East Midlands; The Women’s Health Study was funded by the
National Institutes of Health (NIH) grants; CA154647, CA047988, CA182913, HL043851, HL080467,
and HL099355.
History
Citation
BMJ, 2019;366:l4570
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Diabetes Research Centre
The study specific summary data included in the meta-analysis can be obtained from
the corresponding author; ulf.ekelund@nih.no;The file associated with this record is under embargo until publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.